Journal of Pharmaceutical Investigation

Papers
(The TQCC of Journal of Pharmaceutical Investigation is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Microneedle for transdermal drug delivery: current trends and fabrication145
Recent advances of nanocellulose in drug delivery systems70
Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays57
Characterization studies of novel series of cobalt (II), nickel (II) and copper (II) complexes: DNA binding and antibacterial activity47
Nanomedicine-based commercial formulations: current developments and future prospects42
Physical properties of nanoparticles do matter42
Mitochondrial targeted strategies and their application for cancer and other diseases treatment34
Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research34
Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors33
Emerging nanoparticulate drug delivery systems of metformin31
Comparison of solubility enhancement by solid dispersion and micronized butein and its correlation with in vivo study30
Cellulose and its derivatives for application in 3D printing of pharmaceuticals30
Fabrication of aerosol-based nanoparticles and their applications in biomedical fields29
Smart pH-responsive nanomedicines for disease therapy29
Application of conductive poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) polymers in potential biomedical engineering29
Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects28
Recent trends of self-emulsifying drug delivery system for enhancing the oral bioavailability of poorly water-soluble drugs28
Development of clindamycin-loaded alginate/pectin/hyaluronic acid composite hydrogel film for the treatment of MRSA-infected wounds27
Recent progress in cancer immunotherapy approaches based on nanoparticle delivery devices26
Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches25
Intestinal membrane transporter-mediated approaches to improve oral drug delivery25
Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals23
Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy22
Nanoparticles of ZnO/Berberine complex contract COVID-19 and respiratory co-bacterial infection in addition to elimination of hydroxychloroquine toxicity19
Lipid-based nanoparticles for photosensitive drug delivery systems19
Pharmaceutical application and development of fixed-dose combination: dosage form review17
Response surface optimization of self nano-emulsifying drug delivery system of rosuvastatin calcium for hepatocellular carcinoma17
Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation17
Recent advances in nano/microparticle-based oral vaccines16
Effects of lipid nanoparticles on physicochemical properties, cellular uptake, and lymphatic uptake of 6-methoxflavone15
Proliposome powder or tablets for generating inhalable liposomes using a medical nebulizer15
Selenium nanostructure: Progress towards green synthesis and functionalization for biomedicine15
Exemestane encapsulated copolymers L121/F127/GL44 based mixed micelles: solubility enhancement and in vitro cytotoxicity evaluation using MCF-7 breast cancer cells14
Development of immunotherapy and nanoparticles-based strategies for the treatment of Parkinson’s disease14
Development of topical natural based film forming system loaded propolis from stingless bees for wound healing application14
Active targeting via ligand-anchored pH-responsive strontium nanoparticles for efficient nucleic acid delivery into breast cancer cells14
Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines13
Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals13
Micronization of a poorly water-soluble drug, fenofibrate, via supercritical-fluid-assisted spray-drying13
Microemulsion as a promising carrier for nose to brain delivery: journey since last decade13
Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cancer13
Three-Dimensional Printing for Oral Pharmaceutical Dosage Forms12
Development of a zero-order kinetics drug release floating tablet with anti–flip-up design fabricated by 3D-printing technique12
pH-sensitive beads containing curcumin loaded nanostructured lipid carriers for a colon targeted oral delivery system12
Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain12
Progress and recent trends in photodynamic therapy with nanoparticles12
A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches12
Anti-inflammatory effects of a topical emulsion containing Helianthus annuus oil, glycerin, and vitamin B3 in mice12
Recent studies on modulating hyaluronic acid-based hydrogels for controlled drug delivery12
A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor11
Thermosensitive nasal in situ gelling systems of rufinamide formulated using modified tamarind seed xyloglucan for direct nose-to-brain delivery: design, physical characterization, and in vivo evaluat11
A quality by design approach in oral extended release drug delivery systems: where we are and where we are going?11
Quality by Design (QbD) application for the pharmaceutical development process11
0.033390998840332